Jane Street Group LLC Sells 6,008 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Jane Street Group LLC reduced its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 72.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,265 shares of the company’s stock after selling 6,008 shares during the quarter. Jane Street Group LLC’s holdings in Addus HomeCare were worth $284,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Dimensional Fund Advisors LP grew its stake in shares of Addus HomeCare by 1.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 692,713 shares of the company’s stock valued at $86,833,000 after buying an additional 10,434 shares in the last quarter. Capital Research Global Investors bought a new position in shares of Addus HomeCare in the fourth quarter valued at $51,149,000. TimesSquare Capital Management LLC grew its stake in shares of Addus HomeCare by 28.5% in the fourth quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company’s stock valued at $44,593,000 after buying an additional 78,835 shares in the last quarter. Invesco Ltd. grew its stake in shares of Addus HomeCare by 6.5% in the fourth quarter. Invesco Ltd. now owns 346,120 shares of the company’s stock valued at $43,386,000 after buying an additional 21,266 shares in the last quarter. Finally, Northern Trust Corp grew its stake in shares of Addus HomeCare by 3.3% in the fourth quarter. Northern Trust Corp now owns 285,872 shares of the company’s stock valued at $35,834,000 after buying an additional 9,122 shares in the last quarter. 95.35% of the stock is owned by institutional investors.

Insider Buying and Selling at Addus HomeCare

In other news, EVP Michael D. Wattenbarger sold 2,045 shares of the firm’s stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total value of $235,175.00. Following the transaction, the executive vice president now owns 7,796 shares in the company, valued at $896,540. This trade represents a 20.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 4.60% of the company’s stock.

Addus HomeCare Stock Up 1.3%

NASDAQ ADUS opened at $112.68 on Wednesday. The firm has a market cap of $2.07 billion, a price-to-earnings ratio of 25.78, a price-to-earnings-growth ratio of 1.41 and a beta of 0.85. The business has a 50-day moving average price of $105.05 and a 200-day moving average price of $112.61. Addus HomeCare Co. has a twelve month low of $88.96 and a twelve month high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, May 5th. The company reported $1.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $337.71 million for the quarter, compared to the consensus estimate of $341.66 million. During the same period in the prior year, the business posted $1.21 earnings per share. The company’s quarterly revenue was up 20.3% compared to the same quarter last year. Research analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Analysts Set New Price Targets

ADUS has been the subject of a number of recent research reports. Stephens reissued an “overweight” rating and issued a $142.00 target price on shares of Addus HomeCare in a research report on Wednesday, March 12th. JMP Securities reaffirmed a “market outperform” rating and issued a $150.00 price target on shares of Addus HomeCare in a research note on Tuesday, April 22nd. Macquarie boosted their target price on Addus HomeCare from $129.00 to $133.00 and gave the stock an “outperform” rating in a research note on Thursday, May 8th. Finally, Wall Street Zen cut Addus HomeCare from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating, six have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $142.57.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.